氟哌啶醇 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "氟哌啶醇" in Chinese language version.

refsWebsite

Global rank Chinese rank

27nih.gov

4^th place

5^th place

24doi.org

2^nd place

23^rd place

13web.archive.org

1^st place

9semanticscholar.org

11^th place

332^nd place

6books.google.com

3^rd place

8^th place

5drugs.com

399^th place

208^th place

3archive.org

6^th place

4^th place

2tga.gov.au

3,984^th place

1,603^rd place

1worldcat.org

5^th place

12^th place

1in.gov.br

3,151^st place

low place

1escholarship.org

1,523^rd place

3,448^th place

1handle.net

102^nd place

492^nd place

1clincalc.com

3,912^th place

5,917^th place

1medicinescomplete.com

low place

9,960^th place

1chemeurope.com

low place

1psychiatryonline.org

4,032^nd place

4,931^st place

1choosingwisely.org

7,197^th place

9,501^st place

1fda.gov

447^th place

581^st place

1consensus.app

low place

1mdedge.com

low place

1medicines.org.uk

3,823^rd place

3,456^th place

1reading.ac.uk

8,258^th place

7,723^rd place

1sigmaaldrich.com

924^th place

1,167^th place

1hoelzel-biotech.com

low place

1springer.com

274^th place

320^th place

archive.org

Joint Formulary Committee. British National Formulary (BNF) 65th. London, England: Pharmaceutical Press. 2013: 229–30. ISBN 978-0-85711-084-8.
Cavanaugh SV. Psychiatric emergencies. The Medical Clinics of North America. September 1986, 70 (5): 1185–1202. PMID 3736271. doi:10.1016/S0025-7125(16)30919-1.
Joint Formulary Committee, BMJ (编). 4.2.1. British National Formulary 57. United Kingdom: Royal Pharmaceutical Society of Great Britain. March 2009: 192. ISBN 978-0-85369-845-6. Withdrawal of antipsychotic drugs after long-term therapy should always be gradual and closely monitored to avoid the risk of acute withdrawal syndromes or rapid relapse.

books.google.com

Sneader W. Drug discovery : a history Rev. and updated. Chichester: Wiley. 2005: 124. ISBN 978-0-471-89979-2. （原始内容存档于2015-12-08）.
Ravina E. The evolution of drug discovery: from traditional medicines to modern drugs 1. Aufl. Weinheim: Wiley-VCH. 2011: 62. ISBN 978-3-527-32669-3. （原始内容存档于2015-12-08）.
Stevens A. Health care needs assessment: the epidemiologically based needs assessment reviews 2nd. Abingdon: Radcliffe Medical. 2004: 202. ISBN 978-1-85775-892-4. （原始内容存档于2015-12-08）.
Haddad PM, Dursun S, Deakin B. Adverse Syndromes and Psychiatric Drugs: A Clinical Guide. OUP Oxford. 2004: 207–216. ISBN 9780198527480 （英语）.
Escobar JI, Marin H. Clinical Psychopharmacology: A Practical Approach. World Scientific. 2013: 69. ISBN 978-981-4578-37-0 （英语）.
Adams JG. Emergency Medicine E-Book: Clinical Essentials (Expert Consult -- Online). Elsevier Health Sciences. 2012: 1635. ISBN 978-1-4557-3394-1 （英语）.

chemeurope.com

Haloperidol. CHEMEUROPE.com. [2024--12-14].

choosingwisely.org

American Academy of Hospice and Palliative Medicine. Five Things Physicians and Patients Should Question. Choosing Wisely: An Initiative of the ABIM Foundation (American Academy of Hospice and Palliative Medicine). [2013-08-01]. （原始内容存档于2013-09-01）. , which cites
- Smith TJ, Ritter JK, Poklis JL, Fletcher D, Coyne PJ, Dodson P, Parker G. ABH gel is not absorbed from the skin of normal volunteers. Journal of Pain and Symptom Management. May 2012, 43 (5): 961–966. PMID 22560361. doi:10.1016/j.jpainsymman.2011.05.017 .

clincalc.com

Haloperidol - Drug Usage Statistics. ClinCalc. [2022-10-07].

consensus.app

Haloperidol Withdrawal Symptoms: An Overview.

doi.org

Kudo S, Ishizaki T. Pharmacokinetics of haloperidol: an update. Clinical Pharmacokinetics. December 1999, 37 (6): 435–456. PMID 10628896. S2CID 71360020. doi:10.2165/00003088-199937060-00001.
Kostrzewa RM. Survey of Selective Monoaminergic Neurotoxins Targeting Dopaminergic, Noradrenergic, and Serotoninergic Neurons. Handbook of Neurotoxicity. Cham: Springer International Publishing. 2022: 159–198. ISBN 978-3-031-15079-1. doi:10.1007/978-3-031-15080-7_53.
Igarashi, Kazuo. The Possible Role of an Active Metafbollte Derived from the Neuroleptic Agent Haloperidol in Drug-Induced Parkinsonism. Journal of Toxicology: Toxin Reviews. 1998, 17 (1): 27–38. ISSN 0731-3837. doi:10.3109/15569549809006488.
Górska A, Marszałł M, Sloderbach A. Neurotoksyczność pirydyniowych metabolitów haloperydolu [The neurotoxicity of pyridinium metabolites of haloperidol]. Postepy Hig Med Dosw (Online). October 2015, 69: 1169–1175. PMID 26561842. doi:10.5604/17322693.1175009  (不活跃 2024-11-01) （Polish）.
Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). The New England Journal of Medicine. November 2014, 371 (22): 2109–2113. PMID 25427113. S2CID 205116954. doi:10.1056/NEJMra1407298.
Plosker GL. Quetiapine: a pharmacoeconomic review of its use in bipolar disorder. PharmacoEconomics. July 2012, 30 (7): 611–631. PMID 22559293. doi:10.2165/11208500-000000000-00000.
Giannini AJ, Underwood NA, Condon M. Acute ketamine intoxication treated by haloperidol: a preliminary study. American Journal of Therapeutics. November 2000, 7 (6): 389–391. PMID 11304647. doi:10.1097/00045391-200007060-00008.
Giannini AJ, Eighan MS, Loiselle RH, Giannini MC. Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis. Journal of Clinical Pharmacology. April 1984, 24 (4): 202–204. PMID 6725621. S2CID 42278510. doi:10.1002/j.1552-4604.1984.tb01831.x.
Currier GW. The controversy over "chemical restraint" in acute care psychiatry. Journal of Psychiatric Practice (Lippincott Williams & Wilkins). January 2003, 9 (1): 59–70. PMID 15985915. S2CID 22342074. doi:10.1097/00131746-200301000-00006.
Cavanaugh SV. Psychiatric emergencies. The Medical Clinics of North America. September 1986, 70 (5): 1185–1202. PMID 3736271. doi:10.1016/S0025-7125(16)30919-1.
Allen MH, Currier GW, Hughes DH, Docherty JP, Carpenter D, Ross R. Treatment of behavioral emergencies: a summary of the expert consensus guidelines. Journal of Psychiatric Practice. January 2003, 9 (1): 16–38. PMID 15985913. S2CID 29363701. doi:10.1097/00131746-200301000-00004.
Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP. The expert consensus guideline series. Treatment of behavioral emergencies 2005. Journal of Psychiatric Practice. November 2005, 11 (Suppl 1): 5–25. PMID 16319571. S2CID 72366588. doi:10.1097/00131746-200511001-00002.
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. September 2013, 382 (9896): 951–962. PMID 23810019. S2CID 32085212. doi:10.1016/S0140-6736(13)60733-3.
Halman A, Kong G, Sarris J, Perkins D. Drug-drug interactions involving classic psychedelics: A systematic review. J Psychopharmacol. January 2024, 38 (1): 3–18. PMC 10851641 . PMID 37982394. doi:10.1177/02698811231211219.
Halberstadt AL. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res. January 2015, 277: 99–120. PMC 4642895 . PMID 25036425. doi:10.1016/j.bbr.2014.07.016.
Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport. December 1998, 9 (17): 3897–3902. PMID 9875725. doi:10.1097/00001756-199812010-00024.
American Academy of Hospice and Palliative Medicine. Five Things Physicians and Patients Should Question. Choosing Wisely: An Initiative of the ABIM Foundation (American Academy of Hospice and Palliative Medicine). [2013-08-01]. （原始内容存档于2013-09-01）. , which cites
- Smith TJ, Ritter JK, Poklis JL, Fletcher D, Coyne PJ, Dodson P, Parker G. ABH gel is not absorbed from the skin of normal volunteers. Journal of Pain and Symptom Management. May 2012, 43 (5): 961–966. PMID 22560361. doi:10.1016/j.jpainsymman.2011.05.017 .
- Sattler, Stefan M; Lubberding, Anniek F. Effect of the antipsychotic drug haloperidol on arrhythmias during acute myocardial infarction in a porcine model. IJC Heart & Vasculature. 2019-12-30, 26 (100455) [2024-12-15]. doi:10.1016/j.ijcha.2019.100455.
- Seeman P, Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Molecular Psychiatry. March 1998, 3 (2): 123–134. PMID 9577836. doi:10.1038/sj.mp.4000336 .
- Shan X, Williams AC, Khutoryanskiy VV. Polymer structure and property effects on solid dispersions with haloperidol: Poly(N-vinyl pyrrolidone) and poly(2-oxazolines) studies (PDF). International Journal of Pharmaceutics. November 2020, 590: 119884. PMID 32950665. S2CID 221826541. doi:10.1016/j.ijpharm.2020.119884.
- Granger B, Albu S. The haloperidol story. Annals of Clinical Psychiatry. 2005, 17 (3): 137–140. PMID 16433054. doi:10.1080/10401230591002048.
- López-Muñoz F, Alamo C. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Research Bulletin. April 2009, 79 (2): 130–141. PMID 19186209. S2CID 7720401. doi:10.1016/j.brainresbull.2009.01.005.
- Kennedy SH, Giacobbe P, Placenza F, Hudson CJ, Seeman P, Seeman MV. Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind study. J Affect Disord. September 2014, 166: 139–143. PMID 25012422. doi:10.1016/j.jad.2014.04.014.
- Cohen D, Recalt A. Discontinuing Psychotropic Drugs from Participants in Randomized Controlled Trials: A Systematic Review. Psychother Psychosom. 2019, 88 (2): 96–104. PMID 30923288. doi:10.1159/000496733.

drugs.com

Haloperidol Use During Pregnancy. Drugs.com. 2020-02-10 [2020-09-13].
Haloperidol. The American Society of Health-System Pharmacists. [2015-01-02]. （原始内容存档于2015-01-02）.
Haldol Official FDA information, side effects and uses. Drugs.com. [2013-10-03]. （原始内容存档于2013-10-05）.
Haloperidol at Drugs.com. （原始内容存档于2011-11-22）.
drugs.com. （原始内容存档于2011-08-10）.

escholarship.org

Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). The New England Journal of Medicine. November 2014, 371 (22): 2109–2113. PMID 25427113. S2CID 205116954. doi:10.1056/NEJMra1407298.

fda.gov

FDA Psychopharmacological Drugs Advisory Committee. Briefing Document for ZELDOX CAPSULES (Ziprasidone HCl) (PDF). Food and Drug Administration. 2000-07-09 [2016-09-30]. （原始内容 (PDF)存档于2017-01-19）.

handle.net

hdl.handle.net

World Health Organization. World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. 2021. hdl:10665/345533 . WHO/MHP/HPS/EML/2021.02.

hoelzel-biotech.com

Haloperidol. Hölzel. [2024-12-14].

in.gov.br

Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-03-31 (2023-04-04) [2023-08-16]. （原始内容存档于2023-08-03）（巴西葡萄牙语）.

mdedge.com

Pierre JM. Time to retire haloperidol?. Current Psychiatry: 19.

medicines.org.uk

Haldol Decanoate - Summary of Product Characteristics (SmPC) - (emc). www.medicines.org.uk. [2021-12-26].

medicinescomplete.com

Brayfield, A (编). Haloperidol. Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. 2013 -12-13 [2014-05-29]. 请检查|date=中的日期值 (帮助)

nih.gov

ncbi.nlm.nih.gov

Kudo S, Ishizaki T. Pharmacokinetics of haloperidol: an update. Clinical Pharmacokinetics. December 1999, 37 (6): 435–456. PMID 10628896. S2CID 71360020. doi:10.2165/00003088-199937060-00001.
Górska A, Marszałł M, Sloderbach A. Neurotoksyczność pirydyniowych metabolitów haloperydolu [The neurotoxicity of pyridinium metabolites of haloperidol]. Postepy Hig Med Dosw (Online). October 2015, 69: 1169–1175. PMID 26561842. doi:10.5604/17322693.1175009  (不活跃 2024-11-01) （Polish）.
Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). The New England Journal of Medicine. November 2014, 371 (22): 2109–2113. PMID 25427113. S2CID 205116954. doi:10.1056/NEJMra1407298.
Plosker GL. Quetiapine: a pharmacoeconomic review of its use in bipolar disorder. PharmacoEconomics. July 2012, 30 (7): 611–631. PMID 22559293. doi:10.2165/11208500-000000000-00000.
Giannini AJ, Underwood NA, Condon M. Acute ketamine intoxication treated by haloperidol: a preliminary study. American Journal of Therapeutics. November 2000, 7 (6): 389–391. PMID 11304647. doi:10.1097/00045391-200007060-00008.
Giannini AJ, Eighan MS, Loiselle RH, Giannini MC. Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis. Journal of Clinical Pharmacology. April 1984, 24 (4): 202–204. PMID 6725621. S2CID 42278510. doi:10.1002/j.1552-4604.1984.tb01831.x.
Currier GW. The controversy over "chemical restraint" in acute care psychiatry. Journal of Psychiatric Practice (Lippincott Williams & Wilkins). January 2003, 9 (1): 59–70. PMID 15985915. S2CID 22342074. doi:10.1097/00131746-200301000-00006.
Cavanaugh SV. Psychiatric emergencies. The Medical Clinics of North America. September 1986, 70 (5): 1185–1202. PMID 3736271. doi:10.1016/S0025-7125(16)30919-1.
Allen MH, Currier GW, Hughes DH, Reyes-Harde M, Docherty JP. The Expert Consensus Guideline Series. Treatment of behavioral emergencies. Postgraduate Medicine. May 2001, (Spec No): 1–88; quiz 89–90. PMID 11500996.
Allen MH, Currier GW, Hughes DH, Docherty JP, Carpenter D, Ross R. Treatment of behavioral emergencies: a summary of the expert consensus guidelines. Journal of Psychiatric Practice. January 2003, 9 (1): 16–38. PMID 15985913. S2CID 29363701. doi:10.1097/00131746-200301000-00004.
Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP. The expert consensus guideline series. Treatment of behavioral emergencies 2005. Journal of Psychiatric Practice. November 2005, 11 (Suppl 1): 5–25. PMID 16319571. S2CID 72366588. doi:10.1097/00131746-200511001-00002.
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. September 2013, 382 (9896): 951–962. PMID 23810019. S2CID 32085212. doi:10.1016/S0140-6736(13)60733-3.
Halman A, Kong G, Sarris J, Perkins D. Drug-drug interactions involving classic psychedelics: A systematic review. J Psychopharmacol. January 2024, 38 (1): 3–18. PMC 10851641 . PMID 37982394. doi:10.1177/02698811231211219.
Halberstadt AL. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res. January 2015, 277: 99–120. PMC 4642895 . PMID 25036425. doi:10.1016/j.bbr.2014.07.016.
Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport. December 1998, 9 (17): 3897–3902. PMID 9875725. doi:10.1097/00001756-199812010-00024.
American Academy of Hospice and Palliative Medicine. Five Things Physicians and Patients Should Question. Choosing Wisely: An Initiative of the ABIM Foundation (American Academy of Hospice and Palliative Medicine). [2013-08-01]. （原始内容存档于2013-09-01）. , which cites
- Smith TJ, Ritter JK, Poklis JL, Fletcher D, Coyne PJ, Dodson P, Parker G. ABH gel is not absorbed from the skin of normal volunteers. Journal of Pain and Symptom Management. May 2012, 43 (5): 961–966. PMID 22560361. doi:10.1016/j.jpainsymman.2011.05.017 .
- Nasrallah HA, Chen AT. Multiple neurotoxic effects of haloperidol resulting in neuronal death. Annals of Clinical Psychiatry. August 2017, 29 (3): 195–202. PMID 28738100.
- Nasrallah HA, Chen AT. Multiple neurotoxic effects of haloperidol resulting in neuronal death. Annals of Clinical Psychiatry. August 2017, 29 (3): 195–202. PMID 28738100.
- Seeman P, Tallerico T. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Molecular Psychiatry. March 1998, 3 (2): 123–134. PMID 9577836. doi:10.1038/sj.mp.4000336 .
- Shan X, Williams AC, Khutoryanskiy VV. Polymer structure and property effects on solid dispersions with haloperidol: Poly(N-vinyl pyrrolidone) and poly(2-oxazolines) studies (PDF). International Journal of Pharmaceutics. November 2020, 590: 119884. PMID 32950665. S2CID 221826541. doi:10.1016/j.ijpharm.2020.119884.
- Granger B, Albu S. The haloperidol story. Annals of Clinical Psychiatry. 2005, 17 (3): 137–140. PMID 16433054. doi:10.1080/10401230591002048.
- López-Muñoz F, Alamo C. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Research Bulletin. April 2009, 79 (2): 130–141. PMID 19186209. S2CID 7720401. doi:10.1016/j.brainresbull.2009.01.005.
- Kennedy SH, Giacobbe P, Placenza F, Hudson CJ, Seeman P, Seeman MV. Depression treatment by withdrawal of short-term low-dose antipsychotic, a proof-of-concept randomized double-blind study. J Affect Disord. September 2014, 166: 139–143. PMID 25012422. doi:10.1016/j.jad.2014.04.014.
- Cohen D, Recalt A. Discontinuing Psychotropic Drugs from Participants in Randomized Controlled Trials: A Systematic Review. Psychother Psychosom. 2019, 88 (2): 96–104. PMID 30923288. doi:10.1159/000496733.
- Hofmeyr JM. The use of haloperidol as a long-acting neuroleptic in game capture operations. Journal of the South African Veterinary Association. December 1981, 52 (4): 273–282. PMID 6122740.
toxnet.nlm.nih.gov
- LACTMED: Haloperidol. 2018-10-31 [2019-01-18].
pmc.ncbi.nlm.nih.gov
- Sattler, Stefan M; Lubberding, Anniek F. Effect of the antipsychotic drug haloperidol on arrhythmias during acute myocardial infarction in a porcine model. IJC Heart & Vasculature. 2019-12-30, 26 (100455) [2024-12-15]. doi:10.1016/j.ijcha.2019.100455.

psychiatryonline.org

Work Group on Schizophrenia. Practice Guideline for the Treatment of Patients With Schizophrenia Second. [2014-04-21]. （原始内容存档于2012-03-27）.

reading.ac.uk

centaur.reading.ac.uk

Shan X, Williams AC, Khutoryanskiy VV. Polymer structure and property effects on solid dispersions with haloperidol: Poly(N-vinyl pyrrolidone) and poly(2-oxazolines) studies (PDF). International Journal of Pharmaceutics. November 2020, 590: 119884. PMID 32950665. S2CID 221826541. doi:10.1016/j.ijpharm.2020.119884.

semanticscholar.org

api.semanticscholar.org

Kudo S, Ishizaki T. Pharmacokinetics of haloperidol: an update. Clinical Pharmacokinetics. December 1999, 37 (6): 435–456. PMID 10628896. S2CID 71360020. doi:10.2165/00003088-199937060-00001.
Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). The New England Journal of Medicine. November 2014, 371 (22): 2109–2113. PMID 25427113. S2CID 205116954. doi:10.1056/NEJMra1407298.
Giannini AJ, Eighan MS, Loiselle RH, Giannini MC. Comparison of haloperidol and chlorpromazine in the treatment of phencyclidine psychosis. Journal of Clinical Pharmacology. April 1984, 24 (4): 202–204. PMID 6725621. S2CID 42278510. doi:10.1002/j.1552-4604.1984.tb01831.x.
Currier GW. The controversy over "chemical restraint" in acute care psychiatry. Journal of Psychiatric Practice (Lippincott Williams & Wilkins). January 2003, 9 (1): 59–70. PMID 15985915. S2CID 22342074. doi:10.1097/00131746-200301000-00006.
Allen MH, Currier GW, Hughes DH, Docherty JP, Carpenter D, Ross R. Treatment of behavioral emergencies: a summary of the expert consensus guidelines. Journal of Psychiatric Practice. January 2003, 9 (1): 16–38. PMID 15985913. S2CID 29363701. doi:10.1097/00131746-200301000-00004.
Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP. The expert consensus guideline series. Treatment of behavioral emergencies 2005. Journal of Psychiatric Practice. November 2005, 11 (Suppl 1): 5–25. PMID 16319571. S2CID 72366588. doi:10.1097/00131746-200511001-00002.
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. September 2013, 382 (9896): 951–962. PMID 23810019. S2CID 32085212. doi:10.1016/S0140-6736(13)60733-3.
Shan X, Williams AC, Khutoryanskiy VV. Polymer structure and property effects on solid dispersions with haloperidol: Poly(N-vinyl pyrrolidone) and poly(2-oxazolines) studies (PDF). International Journal of Pharmaceutics. November 2020, 590: 119884. PMID 32950665. S2CID 221826541. doi:10.1016/j.ijpharm.2020.119884.
López-Muñoz F, Alamo C. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Research Bulletin. April 2009, 79 (2): 130–141. PMID 19186209. S2CID 7720401. doi:10.1016/j.brainresbull.2009.01.005.

sigmaaldrich.com

Sigma data sheet on haloperidol (PDF).

springer.com

adisinsight.springer.com

CLR 3001. AdisInsight. 27 August 2019 [13 August 2024].

tga.gov.au

ebs.tga.gov.au

Product Information Serenace (PDF). TGA eBusiness Services. Aspen Pharma Pty Ltd. 2011-09-29 [2014-05-29]. （原始内容存档于2017-03-14）.

tga.gov.au

Prescribing medicines in pregnancy database. Australian Government. 2014-03-03 [2015-01-02]. （原始内容存档于2014-04-08）.

web.archive.org

Product Information Serenace (PDF). TGA eBusiness Services. Aspen Pharma Pty Ltd. 2011-09-29 [2014-05-29]. （原始内容存档于2017-03-14）.
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-03-31 (2023-04-04) [2023-08-16]. （原始内容存档于2023-08-03）（巴西葡萄牙语）.
Haloperidol. The American Society of Health-System Pharmacists. [2015-01-02]. （原始内容存档于2015-01-02）.
Prescribing medicines in pregnancy database. Australian Government. 2014-03-03 [2015-01-02]. （原始内容存档于2014-04-08）.
Sneader W. Drug discovery : a history Rev. and updated. Chichester: Wiley. 2005: 124. ISBN 978-0-471-89979-2. （原始内容存档于2015-12-08）.
Ravina E. The evolution of drug discovery: from traditional medicines to modern drugs 1. Aufl. Weinheim: Wiley-VCH. 2011: 62. ISBN 978-3-527-32669-3. （原始内容存档于2015-12-08）.
Stevens A. Health care needs assessment: the epidemiologically based needs assessment reviews 2nd. Abingdon: Radcliffe Medical. 2004: 202. ISBN 978-1-85775-892-4. （原始内容存档于2015-12-08）.
Haldol Official FDA information, side effects and uses. Drugs.com. [2013-10-03]. （原始内容存档于2013-10-05）.
Work Group on Schizophrenia. Practice Guideline for the Treatment of Patients With Schizophrenia Second. [2014-04-21]. （原始内容存档于2012-03-27）.
American Academy of Hospice and Palliative Medicine. Five Things Physicians and Patients Should Question. Choosing Wisely: An Initiative of the ABIM Foundation (American Academy of Hospice and Palliative Medicine). [2013-08-01]. （原始内容存档于2013-09-01）. , which cites
- Smith TJ, Ritter JK, Poklis JL, Fletcher D, Coyne PJ, Dodson P, Parker G. ABH gel is not absorbed from the skin of normal volunteers. Journal of Pain and Symptom Management. May 2012, 43 (5): 961–966. PMID 22560361. doi:10.1016/j.jpainsymman.2011.05.017 .
- FDA Psychopharmacological Drugs Advisory Committee. Briefing Document for ZELDOX CAPSULES (Ziprasidone HCl) (PDF). Food and Drug Administration. 2000-07-09 [2016-09-30]. （原始内容 (PDF)存档于2017-01-19）.
- Haloperidol at Drugs.com. （原始内容存档于2011-11-22）.
- drugs.com. （原始内容存档于2011-08-10）.

worldcat.org

Igarashi, Kazuo. The Possible Role of an Active Metafbollte Derived from the Neuroleptic Agent Haloperidol in Drug-Induced Parkinsonism. Journal of Toxicology: Toxin Reviews. 1998, 17 (1): 27–38. ISSN 0731-3837. doi:10.3109/15569549809006488.

氟哌啶醇 (Chinese Wikipedia)

archive.org

books.google.com

chemeurope.com

choosingwisely.org

clincalc.com

consensus.app

doi.org

drugs.com

escholarship.org

fda.gov

handle.net

hdl.handle.net

hoelzel-biotech.com

in.gov.br

mdedge.com

medicines.org.uk

medicinescomplete.com

nih.gov

ncbi.nlm.nih.gov

toxnet.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

psychiatryonline.org

reading.ac.uk

centaur.reading.ac.uk

semanticscholar.org

api.semanticscholar.org

sigmaaldrich.com

springer.com

adisinsight.springer.com

tga.gov.au

ebs.tga.gov.au

tga.gov.au

web.archive.org

worldcat.org